These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2262 related articles for article (PubMed ID: 3495737)

  • 21. Endothelium-derived relaxing and contracting factors.
    Furchgott RF; Vanhoutte PM
    FASEB J; 1989 Jul; 3(9):2007-18. PubMed ID: 2545495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelium-derived nitric oxide relaxes nonvascular smooth muscle.
    Buga GM; Gold ME; Wood KS; Chaudhuri G; Ignarro LJ
    Eur J Pharmacol; 1989 Feb; 161(1):61-72. PubMed ID: 2542037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative pharmacology of endothelium-derived relaxing factor and nitric oxide.
    Shikano K; Long CJ; Ohlstein EH; Berkowitz BA
    J Pharmacol Exp Ther; 1988 Dec; 247(3):873-81. PubMed ID: 2849673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acetylcholine stimulates release of endothelium-derived relaxing factor in coronary arteries of human organ donors.
    Blaise GA; Stewart DJ; Guérard MJ
    Can J Cardiol; 1993 Nov; 9(9):813-20. PubMed ID: 8281481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.
    Ignarro LJ; Buga GM; Wood KS; Byrns RE; Chaudhuri G
    Proc Natl Acad Sci U S A; 1987 Dec; 84(24):9265-9. PubMed ID: 2827174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Regulation of vascular tone by the endothelium].
    Busse R; Bassenge E
    Z Kardiol; 1985; 74 Suppl 7():99-106. PubMed ID: 3004057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of oxidative metabolism on endothelium-dependent vascular relaxation of isolated vessels.
    Cappelli-Bigazzi M; Battaglia C; Pannain S; Chiariello M; Ambrosio G
    J Mol Cell Cardiol; 1997 Mar; 29(3):871-9. PubMed ID: 9152848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Release of intact endothelium-derived relaxing factor depends on endothelial superoxide dismutase activity.
    Mügge A; Elwell JH; Peterson TE; Harrison DG
    Am J Physiol; 1991 Feb; 260(2 Pt 1):C219-25. PubMed ID: 1847583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide.
    Myers PR; Minor RL; Guerra R; Bates JN; Harrison DG
    Nature; 1990 May; 345(6271):161-3. PubMed ID: 2110626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Inhibition of platelet activation by endothelium-derived relaxing factor EDRF/NO and NO releasing dilator substances].
    Bassenge E
    Z Kardiol; 1991; 80 Suppl 5():17-21. PubMed ID: 1776330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical.
    Ignarro LJ; Byrns RE; Buga GM; Wood KS
    Circ Res; 1987 Dec; 61(6):866-79. PubMed ID: 2890446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelial dysfunction and vascular disease.
    Vanhoutte PM
    Verh K Acad Geneeskd Belg; 1998; 60(3):251-66. PubMed ID: 9803882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Endothelial relaxation factor as a local modulator of arterial function. The possibility of stabilization].
    Vedernikov IuP; Gräzer T; Osis IuG
    Fiziol Zh SSSR Im I M Sechenova; 1988 Feb; 74(2):153-61. PubMed ID: 3259514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Similar responsiveness of smooth muscle of the canine basilar artery to EDRF and nitric oxide.
    Katusic ZS; Marshall JJ; Kontos HA; Vanhoutte PM
    Am J Physiol; 1989 Oct; 257(4 Pt 2):H1235-9. PubMed ID: 2552840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The discovery of nitric oxide as the endogenous nitrovasodilator.
    Moncada S; Palmer RM; Higgs EA
    Hypertension; 1988 Oct; 12(4):365-72. PubMed ID: 3049340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thimerosal, an inhibitor of endothelial acyl-coenzyme A: lysolecithin acyltransferase, stimulates the production of a nonprostanoid endothelium-derived vascular relaxing factor.
    Förstermann U; Goppelt-Strübe M; Frölich JC; Busse R
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():1108-11. PubMed ID: 2960154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of photodynamic therapy on the endothelium-dependent relaxation of isolated rat aortas.
    Gilissen MJ; van de Merbel-de Wit LE; Star WM; Koster JF; Sluiter W
    Cancer Res; 1993 Jun; 53(11):2548-52. PubMed ID: 8495418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endothelium-derived vascular relaxing factor.
    Peach MJ; Loeb AL; Singer HA; Saye J
    Hypertension; 1985; 7(3 Pt 2):I94-100. PubMed ID: 2987129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interactions between endothelium-derived relaxing factors in the rat hepatic artery: focus on regulation of EDHF.
    Zygmunt PM; Plane F; Paulsson M; Garland CJ; Högestätt ED
    Br J Pharmacol; 1998 Jul; 124(5):992-1000. PubMed ID: 9692786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition by sulfhydryl compounds of vascular relaxation induced by nitric oxide and endothelium-derived relaxing factor.
    Jia L; Furchgott RF
    J Pharmacol Exp Ther; 1993 Oct; 267(1):371-8. PubMed ID: 8229764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 114.